Rigoni et al. summarise expert and public opinions on the regulation of MDMA collected in relation to a pop-up installation (the 'XTC store') in Utrecht (the Netherlands) highlighting support for a strictly regulated market for MDMA products.
PRI and TIJ provide an overview and highlight how the criminalisation of drugs remains a key contributing factor to the rising global prison population and prison overcrowding.
Mainline review the current harm reduction programmes in Nepal from the perspective of women who inject drugs, and formulate recommendations to improve service delivery.
The EMCDDA shed light on emerging trends, challenges, and policy implications surrounding drug use in Europe up until the end of 2022, revealing high availability of substances and a greater need for harm reduction services.
The UNAIDS Reference Group on HIV and Human Rights argues criminalisation is harmful and deadly, fuels the HIV pandemic and promotes human rights violations.
Barnett et al. found that Black people and other racialised groups in the U.S. are less likely to obtain prescriptions for buprenorphine, naloxone and benzodiazepines than their white counterparts.
EHRA publish their latest edition of CHECK magazine, focusing on the disproportionate levels of stigmatisation and discrimination that women who use drugs face as a result of existing gender inequalities and prohibitionist policies.
The Civic Futures Initiative explore (among other 'wars') the impact that Duterte’s oppressive and securitised 'war on drugs' in the Philippines had on the civic space of those who advocate against the drug policy and document abuses under it.
Rhodes and Lancaster argue that state responses to drug deaths crises rarely account for the long-term causes that push people who use drugs into premature death.
